Archive: News
-
Frontline Systemic Therapy in HCC Patients
Aiwu Ruth He, MD, PhD, highlights factors that influence her use of frontline systemic therapy in patients with unresectable hepatocellular carcinoma.
Category: News
-
The Marshall Family Faces Off Against TNBC
“In reflecting on this journey, the Marshalls discussed their choice to write a book about it. It came, in part, from taking a hard look at the patient and provider perspectives of a cancer journey. The pair saw the opportunity to convey to other health care providers how to best communicate with and understand their patients.”
Category: News
-
The Cost Of Delaying Medical Care During A Pandemic
What are the causes — and consequences — of delaying medical care? Dr. John Marshall discusses the health crisis unfolding in the shadow of the pandemic, and the long-term effects of missing doctor visits on the Kojo Nnamdi show.
Category: News
-
Oncologist Is Humbled, Inspired by His Patients
This Black History Month, PanCan is celebrating Marcus Noel, MD, who focuses on caring for pancreatic cancer patients and developing new, better treatment options for them. Read more about Dr. Noel’s incredible work in the pancreatic cancer space.
Category: News
-
Off Our Chests: John Marshall, MD, and Liza Marshall Recount Her TNBC Journey
Dr. John Marshall and his wife, Liza, recount the challenging journey of Liza’s triple-negative breast cancer diagnosis and how Dr. Marshall’s career as a gastrointestinal oncologist played into the caregiving process.
Category: News
-
Targeted Talks: Gut Microbiome
In season 2, episode 2 of Targeted Talks, Cathy Eng, MD, speaks with Benjamin Weinberg, MD, about the gut microbiome, and how the presence of certain microbiota impact the onset and intensity of disease as well as the potential response to certain treatments.
Category: News
-
Off Our Chests
Learn more about the new book by Dr. John Marshall and his wife Liza Marshall. In a joint statement they explained, “we wrote the book to help others learn about what a diagnosis of cancer means for a patient, for a family, for a caregiver, and for an oncologist so that those who walk that path together might find both support and insight to help light the way.”
Category: News
-
Ask the Doctor- Interview with Dr. John L. Marshall
In an interview with Cancer Wellness Magazine, Dr. John L. Marshall shares his thoughts on the rising rates of early-onset colorectal cancers.
Category: News
-
ASCO’s recognition of molecular profiling in GI cancers as the “Advance of the Year”
According to Dr. Louis M. Weiner, Professor and Director of Georgetown Lombardi Comprehensive Cancer Center, “ASCO’s recognition of molecular profiling in GI cancers as the ‘Advance of the Year’ validates the mission and work of Lombardi’s Ruesch Center for the Cure of GI Cancers. Since its founding over 10 years ago, the Ruesch Center has prioritized the science of precision medicine through education, building collaborative research networks, and dedicated funding all supporting precision medicine in GI cancers. ASCO’s selection of our collective progress reinforces and re-energizes us all. We are indebted to John Marshall, MD for his vision, energy, and wisdom in bringing this important initiative to life and then nurturing it.”
Category: News
-
Precision Medicine, Targeted Therapy, and ZIP Codes: ASCO GI 2021
The Doximity Op-Med, authored by Former Ruesch Center faculty member Mohamed Salem, provides an excellent review of a selection of ASCO GI-presented research. This article highlights his ongoing study, in collaboration with The Ruesch Center’s Marion Hartley and Georgetown’s Kristi Graves, into socioeconomic status and survival outcomes in patients with gastrointestinal cancers.
Category: News